Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Insti... von Park, Julie R., Villablanca, Judith G., Hero, Barbara, Kushner, Brian H., Wheatley, Keith, Beiske, Klaus H., Ladenstein, Ruth L., Baruchel, Sylvain, Macy, Margaret E., Moreno, Lucas, Seibel, Nita L., Pearson, Andrew D., Matthay, Katherine K., Valteau‐Couanet, Dominique

Volltext

Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab von Ramsower, Colleen A, Rosenthal, Allison, Robetorye, Ryan S, Mwangi, Raphael, Maurer, Matthew, Villa, Diego, McDonnell, Tim, Feldman, Andrew, Cohen, Jonathon B, Habermann, Thomas, Campo, Elias, Clot, Guillem, Bühler, Marco M, Kulis, Marta, Martin-Subero, Jose Ignacio, Giné, Eva, Cook, James R, Hill, Brian, Raess, Philipp W, Beiske, Klaus H, Reichart, Alexander, Hartmann, Sylvia, Holte, Harald, Scott, David, Rimsza, Lisa

Volltext

Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab von Ramsower, Colleen A, Rosenthal, Allison, Robetorye, Ryan S, Mwangi, Raphael, Maurer, Matthew, Villa, Diego, McDonnell, Tim, Feldman, Andrew, Cohen, Jonathon B, Habermann, Thomas, Campo, Elias, Clot, Guillem, Bühler, Marco M, Kulis, Marta, Martin-Subero, Jose Ignacio, Giné, Eva, Cook, James R, Hill, Brian, Raess, Philipp W, Beiske, Klaus H, Reichart, Alexander, Hartmann, Sylvia, Holte, Harald, Scott, David, Rimsza, Lisa

Volltext

11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma von Siaw, Joachim Tetteh, Javanmardi, Niloufar, Van den Eynden, Jimmy, Lind, Dan Emil, Fransson, Susanne, Martinez-Monleon, Angela, Djos, Anna, Sjöberg, Rose-Marie, Östensson, Malin, Carén, Helena, Trøen, Gunhild, Beiske, Klaus, Berbegall, Ana P., Noguera, Rosa, Lai, Wei-Yun, Kogner, Per, Palmer, Ruth H., Hallberg, Bengt, Martinsson, Tommy

Volltext

T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling von Josefsson, Sarah E, Huse, Kanutte, Kolstad, Arne, Beiske, Klaus, Pende, Daniela, Steen, Chloé B, Inderberg, Else Marit, Lingjærde, Ole Christian, Østenstad, Bjørn, Smeland, Erlend B, Levy, Ronald, Irish, Jonathan M, Myklebust, June H

Volltext

TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma von Josefsson, Sarah E, Beiske, Klaus, Blaker, Yngvild N, Førsund, Mette S, Holte, Harald, Østenstad, Bjørn, Kimby, Eva, Köksal, Hakan, Wälchli, Sébastien, Bai, Baoyan, Smeland, Erlend B, Levy, Ronald, Kolstad, Arne, Huse, Kanutte, Myklebust, June H

Volltext

The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era von Blaker, Yngvild Nuvin, Spetalen, Signe, Brodtkorb, Marianne, Lingjærde, Ole Christian, Beiske, Klaus, Østenstad, Bjørn, Sander, Birgitta, Wahlin, Björn Engelbrekt, Melen, Christopher Michael, Myklebust, June Helen, Holte, Harald, Delabie, Jan, Smeland, Erlend Bremertun

Volltext

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup von Martinez-Monleon, Angela, Kryh Öberg, Hanna, Gaarder, Jennie, Berbegall, Ana P., Javanmardi, Niloufar, Djos, Anna, Ussowicz, Marek, Taschner-Mandl, Sabine, Ambros, Inge M., Øra, Ingrid, Sandstedt, Bengt, Beiske, Klaus, Ladenstein, Ruth, Noguera, Rosa, Ambros, Peter F., Gordon Murkes, Lena, Ljungman, Gustaf, Kogner, Per, Fransson, Susanne, Martinsson, Tommy

Volltext

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification von DE BROUWER, Sara, DE PETER, Katleen, DE PAEPE, Anne, LAUREYS, Geneviève, SCHULTE, Johannes H, SCHRAMM, Alexander, VAN DEN BROECKE, Caroline, VERMEULEN, Joëlle, VAN ROY, Nadine, BEISKE, Klaus, RENARD, Marleen, NOGUERA, Rosa, KUMPS, Candy, DELATTRE, Olivier, JANOUEIX-LEROSEY, Isabelle, KOGNER, Per, MARTINSSON, Tommy, NAKAGAWARA, Akira, OHIRA, Miki, CARON, Huib, EGGERT, Angelika, COOLS, Jan, VERSTEEG, Rogier, ZABROCKI, Piotr, SPELEMAN, Frank, PORCU, Michaël, WESTERHOUT, Ellen M, LAKEMAN, Arjan, VANDESOMPELE, Jo, HOEBEECK, Jasmien, VAN MAERKEN, Tom

Volltext

Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma von Bai, Baoyan, Wise, Jillian F., Vodák, Daniel, Nakken, Sigve, Sharma, Ankush, Blaker, Yngvild Nuvin, Brodtkorb, Marianne, Hilden, Vera, Trøen, Gunhild, Ren, Weicheng, Lorenz, Suzanne, Lawrence, Michael S., Myklebost, Ola, Kimby, Eva, Pan-Hammarstrom, Qiang, Meza-Zepeda, Leonardo, Beiske, Klaus, Smeland, Erlend B., Hovig, Eivind, Lingjærde, Ole Christian, Holte, Harald, Myklebust, June Helen

Volltext

Diversity of Intratumoral Regulatory T Cells in Non-Hodgkin Lymphoma von Spasevska, Ivana, Sharma, Ankush, Steen, Chloe B., Josefsson, Sarah, Blaker, Yngvild Nuvin, Rustad, Even H, Meyer, Saskia, Chellappa, Stalin, Kushekhar, Kushi, Kolstad, Arne, Beiske, Klaus, Holte, Harald, Østenstad, Bjørn, Kimby, Eva, Olweus, Johanna, Tasken, Kjetil, Lorenz, Suzanne, Smeland, Erlend B., Alizadeh, Ash A., Huse, Kanutte, Myklebust, June Helen

Volltext

Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy von Menter, Thomas, Tzankov, Alexandar, Zucca, Emanuele, Kimby, Eva, Hultdin, Magnus, Sundström, Christer, Beiske, Klaus, Cogliatti, Sergio, Banz, Yara, Cathomas, Gieri, Karjalainen‐Lindsberg, Marja‐Liisa, Grobholz, Rainer, Mazzucchelli, Luca, Sander, Birgitta, Hawle, Hanne, Hayoz, Stefanie, Dirnhofer, Stefan

Volltext

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling von Myklebust, June H., Brody, Joshua, Kohrt, Holbrook E., Kolstad, Arne, Czerwinski, Debra K., Wälchli, Sébastien, Green, Michael R., Trøen, Gunhild, Liestøl, Knut, Beiske, Klaus, Houot, Roch, Delabie, Jan, Alizadeh, Ash A., Irish, Jonathan M., Levy, Ronald

Volltext

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN -Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a... von Ambros, Inge M, Tonini, Gian-Paolo, Pötschger, Ulrike, Gross, Nicole, Mosseri, Véronique, Beiske, Klaus, Berbegall, Ana P, Bénard, Jean, Bown, Nick, Caron, Huib, Combaret, Valérie, Couturier, Jerome, Defferrari, Raffaella, Delattre, Olivier, Jeison, Marta, Kogner, Per, Lunec, John, Marques, Barbara, Martinsson, Tommy, Mazzocco, Katia, Noguera, Rosa, Schleiermacher, Gudrun, Valent, Alexander, Van Roy, Nadine, Villamon, Eva, Janousek, Dasa, Pribill, Ingrid, Glogova, Evgenia, Attiyeh, Edward F, Hogarty, Michael D, Monclair, Tom F, Holmes, Keith, Valteau-Couanet, Dominique, Castel, Victoria, Tweddle, Deborah A, Park, Julie R, Cohn, Sue, Ladenstein, Ruth, Beck-Popovic, Maja, De Bernardi, Bruno, Michon, Jean, Pearson, Andrew D J, Ambros, Peter F

Volltext

Primary chronic cold agglutinin disease: a population based clinical study of 86 patients von Berentsen, S, Ulvestad, E, Langholm, R, Beiske, K, Hjorth-Hansen, H, Ghanima, W, Sorbo, JH, Tjonnfjord, GE

Volltext

Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma von Bai, Baoyan, Wise, Jillian F., Vodák, Daniel, Nakken, Sigve, Sharma, Ankush, Blaker, Yngvild Nuvin, Brodtkorb, Marianne, Hilden, Vera, Trøen, Gunhild, Ren, Weicheng, Lorenz, Susanne, Lawrence, Michael S., Myklebost, Ola, Kimby, Eva, Pan-Hammarström, Qiang, Steen, Chloé B., Meza-Zepeda, Leonardo A., Beiske, Klaus, Smeland, Erlend B., Hovig, Eivind, Lingjærde, Ole Christian, Holte, Harald, Myklebust, June Helen

Volltext

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis von Leppä, Sirpa, Jørgensen, Judit, Tierens, Anne, Meriranta, Leo, Østlie, Ingunn, de Nully Brown, Peter, Fagerli, Unn-Merete, Larsen, Thomas Stauffer, Mannisto, Susanna, Munksgaard, Lars, Maisenhölder, Martin, Vasala, Kaija, Meyer, Peter, Jerkeman, Mats, Björkholm, Magnus, Fluge, Øystein, Jyrkkiö, Sirkku, Liestøl, Knut, Ralfkiaer, Elisabeth, Spetalen, Signe, Beiske, Klaus, Karjalainen-Lindsberg, Marja-Liisa, Holte, Harald

Volltext

Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma von Spasevska, Ivana, Sharma, Ankush, Steen, Chloé B, Josefsson, Sarah E, Blaker, Yngvild N, Kolstad, Arne, Rustad, Even H, Meyer, Saskia, Isaksen, Kathrine, Chellappa, Stalin, Kushekhar, Kushi, Beiske, Klaus, Førsund, Mette S, Spetalen, Signe, Holte, Harald, Østenstad, Bjørn, Brodtkorb, Marianne, Kimby, Eva, Olweus, Johanna, Taskén, Kjetil, Newman, Aaron M, Lorenz, Susanne, Smeland, Erlend B, Alizadeh, Ash A, Huse, Kanutte, Myklebust, June H

Volltext

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma von Köksal, Hakan, Dillard, Pierre, Josefsson, Sarah E., Maggadottir, Solrun Melkorka, Pollmann, Sylvie, Fåne, Anne, Blaker, Yngvild Nuvin, Beiske, Klaus, Huse, Kanutte, Kolstad, Arne, Holte, Harald, Kvalheim, Gunnar, Smeland, Erlend B., Myklebust, June H., Inderberg, Else Marit, Wälchli, Sébastien

Volltext

Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study von Ree, Anne Hansen, Nygaard, Vigdis, Boye, Kjetil, Heinrich, Daniel, Dueland, Svein, Bergheim, Inger Riise, Johansen, Christin, Beiske, Klaus, Negård, Anne, Lund-Iversen, Marius, Nygaard, Vegard, Hovig, Eivind, Nakken, Sigve, Nasser, Salah, Julsrud, Lars, Reisse, Claudius H., Ruud, Espen A., Kristensen, Vessela N., Flørenes, Vivi A., Geitvik, Gry A., Lingjærde, Ole Christian, Børresen-Dale, Anne-Lise, Russnes, Hege G., Mælandsmo, Gunhild M., Flatmark, Kjersti

Volltext